Managing Infectious Disease Outbreaks Through Rapid Pathogen Genome Sequencing

Total Page:16

File Type:pdf, Size:1020Kb

Managing Infectious Disease Outbreaks Through Rapid Pathogen Genome Sequencing BRIEFING PAPER Managing infectious disease outbreaks through rapid pathogen genome sequencing February 2021 oxfordnanoporetech.com 1 Introduction With over two million attributed deaths to Global health security depends on the rapid potential association of novel pathogen variants recognition and containment of infectious diseases (such as the COVID-19 B1.1.7 and B1.351 variants date and a projected economic cost of and no government can afford to be complacent originally identified in the UK and South Africa) with $28 trillion1, the COVID-19 pandemic has about the risks posed to population health, changes to disease severity, transmission, and economic, political, and social stability and diagnostic and therapeutic efficacy. refocused global attention on the acute, wellbeing. It is possible to be prepared to prevent ever-present threat of infectious disease. and control such threats by investing in intelligent This briefing paper describes when, where, and how and agile public health tools to monitor for potential genomic epidemiology can offer critical and timely risks, enabling responses at appropriate speed and insights for infectious disease experts, public health scale to problems as they appear. professionals, and policy-makers to stay a step ahead of infectious disease threats, responding with Executive summary Genomic epidemiology is a crucial weapon in the maximal effect. public health fight against infectious diseases, • The threat of infectious disease is ever present — providing rapid identification and complete This briefing paper is published by Oxford caused by seasonal and novel viruses, bacteria, characterisation of infectious disease pathogens. Nanopore Technologies. Our low-cost, scalable and fungi — and further compounded by growing As evidenced by the COVID-19 pandemic, genomic genomic sequencing devices have been used antimicrobial resistance epidemiology further supports precise tracking of extensively to rapidly characterise pathogens and pathogen evolution, providing detailed insights into track outbreaks, enabling informed and decisive • Significant outbreaks are an increasing risk, driven sources of infection, routes of transmission, and the action. See page 32 for more information. by globalisation, population growth, urbanisation, and climate change • Preparedness is key to minimising the potentially devastating impacts of these outbreaks • Genomic epidemiology, powered by rapid, accessible sequencing technology, provides vital information and time savings essential for rapid disease identification and control • Investment in national and regional disease surveillance and monitoring infrastructure is critical 2 OXFORD NANOPORE TECHNOLOGIES | SEQUENCING, GENOMIC EPIDEMIOLOGY, AND INFECTIOUS DISEASE [COVID-19 is a] wake-up “ call and a dress rehearsal “ for future challenges. António Guterres, Secretary-General, United Nations2 3 The importance of managing infectious disease threats KEY MESSAGES After an epidemic has subsided, there may be Although diseases passed between humans are the longer-term local, national, and global adverse most urgent concern, infectious agents that cause • Infectious diseases are an increasing threat effects on employment, health, education, trade, disease in wild or domestic animals and plants can • Outbreaks can have devastating health and travel, and quality of life. According to the also have severe economic and environmental economic consequences International Monetary Fund (IMF), the economic impacts, and indirectly or directly harm human impact of the current COVID-19 pandemic could be health; for example, foodborne disease is a major in the region of US $28 trillion1. burden in low and middle-income countries5. Even a relatively small and well-controlled Significant new outbreaks are an ongoing risk, Preparedness is vital to minimise the damage driven by increasing globalisation, population infectious diseases can cause. Even small delays or outbreak can exacerbate existing pressures growth, urbanisation, and climate change. They may mistakes in response can have significant on healthcare systems, whilst major arise from the resurgence of historical infectious implications for public health, and modest changes diseases and the spread of antibiotic resistance, or in outcome have much wider effects. For example, outbreaks may overwhelm them. Serious the emergence of infectious diseases caused by it has been suggested that the 2003 severe acute epidemics also pose significant risks of novel infectious agents (Figure 1). Novel pathogens respiratory syndrome (SARS) outbreak would have are particularly dangerous, because of the time tripled in size had there been a delay of just one wider social and economic destabilisation. needed to understand the disease, and to develop week in applying control measures6. control measures and treatments. Dr Michael Ryan, Executive Director of the World Health Organization Examination of the relative success of New Zealand (WHO) Emergencies Programme, recently in control of the COVID-19 pandemic highlighted described constant outbreaks of serious infectious that the key elements were early, decisive reactions diseases as ‘a new normal’ for which countries need from health authorities, effective surveillance Estimated economic impacts of recent infectious disease outbreaks. to be ready4. (including genomic surveillance systems), and Data from WHO3. (US dollars) targeted testing strategies7. SARS (2003) H1N1 (2009) Ebola (2014-16) COVID-19 (2019-) 40 40-50 53 billion billion billion 4 OXFORD NANOPORE TECHNOLOGIES | SEQUENCING, GENOMIC EPIDEMIOLOGY, AND INFECTIOUS DISEASE 28trillion 2009 2019 H1N1 COVID-19 influenza A 2012 new disease (swine flu) MERS 2014 new disease EBOLA 2003 SARS 2015 new disease 2005 H5N1 Zika Avian flu Figure 1: Selected infectious disease outbreaks in the 21st century Infectious diseases are an increasing threat, for example in 2019 alone the WHO recorded over 100 outbreaks of 19 different infectious diseases, each posing a potential epidemic or pandemic threat3. 5 Understanding infectious diseases KEY MESSAGES A wide range of anti-microbial drugs are currently Given these limitations, control of all human available, though in recent years the spread of infectious diseases relies on a combination of • Effective treatments are not available for all antimicrobial resistance, especially in bacteria, has prevention wherever possible (including actions to pathogens and drug resistance is increasing reduced the effectiveness of some treatments. reduce or block transmission between people) and • Prevention of transmission is critical to Detecting antimicrobial resistance in patients with rapid suppression of outbreaks where they do managing infectious disease bacterial infections is critical to ensuring that occur, alongside the use of effective treatment effective alternative treatments can be used8 or for options, where available. To do this, insights into the • Pathogen genome sequencing is a key the identification of particularly dangerous cases biology and behaviour of the pathogens that cause technique for identifying and understanding where no current antibiotics will work, such as disease are required, and as quickly as possible; infectious organisms carbapenem-resistant infections9. Vaccination to DNA/RNA sequencing is an important tool for prevent infection is possible for certain diseases, obtaining this information. Genomic epidemiology though even then some microbes such as influenza — powered by sequencing — is an essential element virus change so quickly that new vaccinations are in the design of effective prevention and control Infectious diseases are caused by needed every year; for many disease threats, no measures. vaccines exist. pathogenic microorganisms (microbes), including viruses, bacteria, fungi, and parasites. They can cause disease of varying type and severity, and many are easily spread through close contact between people. New human pathogens often come from microbes that normally infect animals, but have also acquired the ability to infect humans. 6 OXFORD NANOPORE TECHNOLOGIES | SEQUENCING, GENOMIC EPIDEMIOLOGY, AND INFECTIOUS DISEASE Types of pathogen and exemplar diseases Viral diseases Declared a global pandemic in March 2020, COVID-19, the respiratory disease caused by SARS-CoV-2, has claimed the lives of over 2 million people to date (February 2021). Bacterial diseases Responsible for over 10,000 deaths and health care costs of $2 bn per year in the US alone, methicillin-resistant Staphylococcus aureus (MRSA) is resistant to many first-line antibiotics. Fungal diseases First described in 2009 and commonly acquired in hospitals, Candida auris is associated with high mortality rate if detected late. Some strains are resistant to all three available classes of antifungals. Parasitic diseases Transmitted by infected mosquitoes, Plasmodium falciparum is the predominant cause of malaria, which results in over 400,000 deaths per year. 7 What is genomic epidemiology? KEY MESSAGES Epidemiology is the study of who develops disease, The rapid development of genome sequencing and why. Understanding how diseases occur and technologies has enabled the use genomic • Genomic epidemiology provides the detailed spread in different groups of people, including which epidemiology for infectious disease control — insights required to prevent and manage people are at greater risk, helps plan strategies to combining genomic data from pathogens with infectious disease outbreaks prevent and manage them.
Recommended publications
  • Recovery of Small Plasmid Sequences Via Oxford Nanopore Sequencing
    bioRxiv preprint doi: https://doi.org/10.1101/2021.02.21.432182; this version posted February 22, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. Recovery of small plasmid sequences via Oxford Nanopore sequencing Ryan R. Wick1*, Louise M. Judd1 , Kelly L. Wyres1 and Kathryn E. Holt1,2 1. Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, VIC, 3004, Australia 2. Department of Infection Biology, London School of Hygiene & Tropical Medicine, London, WC1E 7HT, UK * [email protected] Abstract Oxford Nanopore Technologies (ONT) sequencing platforms currently offer two approaches to whole-genome native-DNA library preparation: ligation and rapid. In this study, we compared these two approaches for bacterial whole-genome sequencing, with a specific aim of assessing their ability to recover small plasmid sequences. To do so, we sequenced DNA from seven plasmid-rich bacterial isolates in three different ways: ONT ligation, ONT rapid and Illumina. Using the Illumina read depths to approximate true plasmid abundance, we found that small plasmids (<20 kbp) were underrepresented in ONT ligation read sets (by a mean factor of ~4) but were not underrepresented in ONT rapid read sets. This effect correlated with plasmid size, with the smallest plasmids being the most underrepresented in ONT ligation read sets. We also found lower rates of chimeric reads in the rapid read sets relative to ligation read sets. These results show that when small plasmid recovery is important, ONT rapid library preparations are preferable to ligation-based protocols.
    [Show full text]
  • Nanopore Sequencing of Long Ribosomal DNA Amplicons Enables
    bioRxiv preprint first posted online Jun. 29, 2018; doi: http://dx.doi.org/10.1101/358572. The copyright holder for this preprint (which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license. Nanopore sequencing of long ribosomal DNA amplicons enables portable and simple biodiversity assessments with high phylogenetic resolution across broad taxonomic scale Henrik Krehenwinkel1,4, Aaron Pomerantz2, James B. Henderson3,4, Susan R. Kennedy1, Jun Ying Lim1,2, Varun Swamy5, Juan Diego Shoobridge6, Nipam H. Patel2,7, Rosemary G. Gillespie1, Stefan Prost2,8 1 Department of Environmental Science, Policy and Management, University of California, Berkeley, USA 2 Department of Integrative Biology, University of California, Berkeley, USA 3 Institute for Biodiversity Science and Sustainability, California Academy of Sciences, San Francisco, USA 4 Center for Comparative Genomics, California Academy of Sciences, San Francisco, USA 5 San Diego Zoo Institute for Conservation Research, Escondido, USA 6 Applied Botany Laboratory, Research and development Laboratories, Cayetano Heredia University, Lima, Perú 7 Department of Molecular and Cell Biology, University of California, Berkeley, USA 8 Research Institute of Wildlife Ecology, Department of Integrative Biology and Evolution, University of Veterinary Medicine, Vienna, Austria Corresponding authors: Henrik Krehenwinkel ([email protected]) and Stefan Prost ([email protected]) Keywords Biodiversity, ribosomal, eukaryotes, long DNA barcodes, Oxford Nanopore Technologies, MinION Abstract Background In light of the current biodiversity crisis, DNA barcoding is developing into an essential tool to quantify state shifts in global ecosystems.
    [Show full text]
  • Genomic Sequencing of SARS-Cov-2: a Guide to Implementation for Maximum Impact on Public Health
    Genomic sequencing of SARS-CoV-2 A guide to implementation for maximum impact on public health 8 January 2021 Genomic sequencing of SARS-CoV-2 A guide to implementation for maximum impact on public health 8 January 2021 Genomic sequencing of SARS-CoV-2: a guide to implementation for maximum impact on public health ISBN 978-92-4-001844-0 (electronic version) ISBN 978-92-4-001845-7 (print version) © World Health Organization 2021 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization (http://www.wipo.int/amc/en/mediation/rules/).
    [Show full text]
  • Using Long Nanopore Reads to Delineate Structural Variants (Svs)
    Using long nanopore reads to delineate structural variants (SVs) in the human genome SVs, including large deletions, duplications, inversions, translocations and copy-number changes are abundant in large genomes, and require long reads for precise characterisation Contact: [email protected] More information at: www.nanoporetech.com and publications.nanoporetech.com Unique Repeat Unique Repeat Unique a) b) a) b) sequence 1 1 sequence 2 2 sequence 3 1,000 60 Short reads Insertions Long A B C D E Reference chromosome 1 40 reads 800 Deletions > 50 bp Short-read assembly 20 Collapsed repeat consensus Unique contig 1 Long-read Bases sequenced (Mb) assembly 600 0 Unique contig 1 Unique contig 3 0 10 20 30 40 V W X Y Z Reference chromosome 2 Single, fully-resolved contig Count Read length (kb) c) > 50 bp 400 chr7 (q33) 7p21.3 15.321.1 15.3 7p14.3 7p14.1 13 11.2 11.21 11.22 11.23 7q21.11 q21.3 7q22.1 7q31.1 7q33 7q34 7q35 36.1 36.3 Scale 50 kb hg38 chr7: 134,550,000 134,600,000 134,650,000 134,700,000 Inversion A D C B E GENCODE v24 comprehensive transcript set (only Basic displayed by default) 200 AKR1B10 AKR1B15 BGPM CALD1 AKR1B15 BGPM Deletion BGPM A B C E AC009276.4 Duplication A B C C C D E 0 1,000 10,000 20,000 30,000 Translocation V W C D E + A B X Y Z Event size (bp) Adapted from Huddleston, J. et al. Discovery and genotyping of structural variation from long-read haploid genome sequence data.
    [Show full text]
  • High-Fidelity Nanopore Sequencing of Ultra-Short DNA Sequences
    bioRxiv preprint doi: https://doi.org/10.1101/552224; this version posted February 16, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Title: High-Fidelity Nanopore Sequencing of Ultra-Short DNA Sequences Authors: Brandon D. Wilson1, Michael Eisenstein2,3, H. Tom Soh2,3,4* Affiliations: 1Department of Chemical Engineering, Stanford University, Stanford, CA 94305, USA. 2Department of Electrical Engineering, Stanford University, Stanford, CA 94305, USA. 3Department of Radiology, Stanford University, Stanford, CA 94305, USA. 4Chan Zuckerberg Biohub, San Francisco, CA 94158, USA. * Correspondence to [email protected] One Sentence Summary: We introduce a simple method of accurately sequencing ultra-short (<100bp) target DNA on a nanopore sequencing platform. Abstract Nanopore sequencing offers a portable and affordable alternative to sequencing-by-synthesis methods but suffers from lower accuracy and cannot sequence ultra-short DNA. This puts applications such as molecular diagnostics based on the analysis of cell-free DNA or single- nucleotide variants (SNV) out of reach. To overcome these limitations, We report a nanopore-based sequencing strategy in Which short target sequences are first circularized and then amplified via rolling-circle amplification to produce long stretches of concatemeric repeats. These can be sequenced on the Oxford Nanopore Technology’s (ONT) MinION platform, and the resulting repeat sequences aligned to produce a highly-accurate consensus that reduces the high error-rate present in the individual repeats.
    [Show full text]
  • Nanopore Sequencing Is a Credible Alternative to Recover Complete Genomes of Geminiviruses
    microorganisms Article Nanopore Sequencing Is a Credible Alternative to Recover Complete Genomes of Geminiviruses Selim Ben Chehida 1 , Denis Filloux 2,3, Emmanuel Fernandez 2,3, Oumaima Moubset 2,3, Murielle Hoareau 1, Charlotte Julian 2,3, Laurence Blondin 2,3, Jean-Michel Lett 1, Philippe Roumagnac 2,3 and Pierre Lefeuvre 1,* 1 CIRAD, UMR PVBMT, F-97410 St Pierre, La Réunion, France; [email protected] (S.B.C.); [email protected] (M.H.); [email protected] (J.-M.L.) 2 CIRAD, PHIM, F-34398 Montpellier, France; [email protected] (D.F.); [email protected] (E.F.); [email protected] (O.M.); [email protected] (C.J.); [email protected] (L.B.); [email protected] (P.R.) 3 PHIM Plant Health Institute, University Montpellier, CIRAD, INRAE, Institut Agro, IRD, F-34398 Montpellier, France * Correspondence: [email protected] Abstract: Next-generation sequencing (NGS), through the implementation of metagenomic protocols, has led to the discovery of thousands of new viruses in the last decade. Nevertheless, these protocols are still laborious and costly to implement, and the technique has not yet become routine for everyday virus characterization. Within the context of CRESS DNA virus studies, we implemented two alternative long-read NGS protocols, one that is agnostic to the sequence (without a priori knowledge of the viral genome) and the other that use specific primers to target a virus (with a priori). Agnostic Citation: Ben Chehida, S.; Filloux, D.; and specific long read NGS-based assembled genomes of two capulavirus strains were compared to Fernandez, E.; Moubset, O.; Hoareau, those obtained using the gold standard technique of Sanger sequencing.
    [Show full text]
  • Direct RNA Nanopore Sequencing of Full-Length Coronavirus Genomes Provides Novel Insights Into Structural Variants and Enables Modification Analysis
    Downloaded from genome.cshlp.org on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press Method Direct RNA nanopore sequencing of full-length coronavirus genomes provides novel insights into structural variants and enables modification analysis Adrian Viehweger,1,2,5 Sebastian Krautwurst,1,2,5 Kevin Lamkiewicz,1,2 Ramakanth Madhugiri,3 John Ziebuhr,2,3 Martin Hölzer,1,2 and Manja Marz1,2,4 1RNA Bioinformatics and High-Throughput Analysis, Friedrich Schiller University Jena, 07743 Jena, Germany; 2European Virus Bioinformatics Center, Friedrich Schiller University Jena, 07743 Jena, Germany; 3Institute of Medical Virology, Justus Liebig University Gießen, 35390 Gießen, Germany; 4Leibniz Institute on Aging–Fritz Lipmann Institute, 07743 Jena, Germany Sequence analyses of RNA virus genomes remain challenging owing to the exceptional genetic plasticity of these viruses. Because of high mutation and recombination rates, genome replication by viral RNA-dependent RNA polymerases leads to populations of closely related viruses, so-called “quasispecies.” Standard (short-read) sequencing technologies are ill-suit- ed to reconstruct large numbers of full-length haplotypes of (1) RNA virus genomes and (2) subgenome-length (sg) RNAs composed of noncontiguous genome regions. Here, we used a full-length, direct RNA sequencing (DRS) approach based on nanopores to characterize viral RNAs produced in cells infected with a human coronavirus. By using DRS, we were able to map the longest (∼26-kb) contiguous read to the viral reference genome. By combining Illumina and Oxford Nanopore sequencing, we reconstructed a highly accurate consensus sequence of the human coronavirus (HCoV)-229E genome (27.3 kb). Furthermore, by using long reads that did not require an assembly step, we were able to identify, in infected cells, diverse and novel HCoV-229E sg RNAs that remain to be characterized.
    [Show full text]
  • De Novo Sequencing and Variant Calling with Nanopores Using Poreseq
    De novo Sequencing and Variant Calling with Nanopores using PoreSeq Tamas Szalay1 & Jene A. Golovchenko1,2* 1School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts 02138 USA 2Department of Physics, Harvard University, Cambridge, Massachusetts 02138 USA *Corresponding author, email: [email protected] 1 1 The single-molecule accuracy of nanopore sequencing has been an area of rapid academic 2 and commercial advancement, but remains challenging for the de novo analysis of genomes. 3 We introduce here a novel algorithm for the error correction of nanopore data, utilizing 4 statistical models of the physical system in order to obtain high accuracy de novo sequences 5 at a range of coverage depths. We demonstrate the technique by sequencing M13 6 bacteriophage DNA to 99% accuracy at moderate coverage as well as its use in an assembly 7 pipeline by sequencing E. coli and ࣅ DNA at a range of coverages. We also show the 8 algorithm’s ability to accurately classify sequence variants at far lower coverage than 9 existing methods. 10 DNA sequencing has proven to be an indispensable technique in biology and medicine, 11 greatly accelerated by the technological developments that led to multiple generations of low 12 cost and high throughput tools1,2. Despite these advances, however, most existing sequencing-by- 13 synthesis techniques remain limited to short reads using expensive devices with complex sample 14 preparation procedures3. 15 Initially proposed two decades ago by Branton, Deamer, and Church4, nanopore 16 sequencing has recently emerged as a serious contender in the crowded field of DNA 17 sequencing.
    [Show full text]
  • A Systematic Benchmark of Nanopore Long Read RNA Sequencing for Transcript Level Analysis in Human Cell Lines
    bioRxiv preprint doi: https://doi.org/10.1101/2021.04.21.440736; this version posted April 22, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. A systematic benchmark of Nanopore long read RNA sequencing for transcript level analysis in human cell lines Authors: Ying Chen1, Nadia M. Davidson2,3, Yuk Kei Wan1, Harshil Patel4, Fei Yao1, Hwee Meng Low1, Christopher Hendra1,5, Laura Watten1, Andre Sim1, Chelsea Sawyer4, Viktoriia Iakovleva1,6, Puay Leng Lee1, Lixia Xin1, Hui En Vanessa Ng7, Jia Min Loo1, Xuewen Ong8, Hui Qi Amanda Ng1, Jiaxu Wang1, Wei Qian Casslynn Koh1, Suk Yeah Polly Poon1, Dominik Stanojevic1,9, Hoang-Dai Tran1, Kok Hao Edwin Lim1, Shen Yon Toh10, Philip Andrew Ewels11, Huck-Hui Ng1, N.Gopalakrishna Iyer10,12, Alexandre Thiery13, Wee Joo Chng6,7,14, Leilei Chen7,15, Ramanuj DasGupta1, Mile Sikic1,9, Yun-Shen Chan1, Boon Ooi Patrick Tan1,7,8, Yue Wan1, Wai Leong Tam1,7,16,17, Qiang Yu1, Chiea Chuan Khor1,12,18, Torsten Wüstefeld1,10,14, Ploy N. Pratanwanich1,19,20, Michael I. Love21,22, Wee Siong Sho Goh1, 23, Sarah B. Ng1, Alicia Oshlack2,24, Jonathan Göke1,10*, SG-NEx consortium Affiliations: 1.Genome Institute of Singapore, Singapore, Singapore 2.Peter MacCallum Cancer Centre, Melbourne, VIC, Australia 3.School of BioSciences, The University of Melbourne, Parkville, Victoria, Australia 4.Bioinformatics and Biostatistics, The
    [Show full text]
  • Biological Nanopores: Engineering on Demand
    life Review Biological Nanopores: Engineering on Demand Ana Crnkovi´c*, Marija Srnko and Gregor Anderluh National Institute of Chemistry, Hajdrihova 19, 1000 Ljubljana, Slovenia; [email protected] (M.S.); [email protected] (G.A.) * Correspondence: [email protected] Abstract: Nanopore-based sensing is a powerful technique for the detection of diverse organic and inorganic molecules, long-read sequencing of nucleic acids, and single-molecule analyses of enzymatic reactions. Selected from natural sources, protein-based nanopores enable rapid, label-free detection of analytes. Furthermore, these proteins are easy to produce, form pores with defined sizes, and can be easily manipulated with standard molecular biology techniques. The range of possible analytes can be extended by using externally added adapter molecules. Here, we provide an overview of current nanopore applications with a focus on engineering strategies and solutions. Keywords: nanopores; pore-forming toxins; sensing; aptamers; oligomerization 1. Introduction Nanopore-based sensing is an emerging technology with great potential for the de- tection of diverse organic molecules, sequencing of nucleic acids, and single-molecule analyses of enzymatic reactions and protein folding. Conceptually, nanopore biosensing belongs to the so-called resistive-pulse methods. A classic example of such a method is the Coulter counter, originally developed in the 1950s to count blood cells [1]. The instrument contains a capillary, which is divided into two parts by a wall containing a 20 µm–2 mm aperture. The capillary is filled with an electrolyte solution and an applied electric field causes ions to move through the opening, creating a constant ionic current. As the blood Citation: Crnkovi´c,A.; Srnko, M.; cells move through the narrow aperture, they partially block the aperture, causing a de- Anderluh, G.
    [Show full text]
  • Nanopore Sequencing the Advantages of Long Reads for Genome Assembly
    WHITE PAPER Nanopore sequencing The advantages of long reads for genome assembly SEPTEMBER 2017 nanoporetech.com nanoporetech.com/publications OXFORD NANOPORE TECHNOLOGIES | THE ADVANTAGESAPPLICATION ANDOF LONG ADVANTAGES READS FOR OF GENOMELONG-READ ASSEMBLY NANOPORE SEQUENCING TO STRUCTURAL VARIATION ANALYSIS Contents 1 De novo assembly 2 Advantages of long-read sequencing for genome assembly 3 Genome assembly tools 4 Case studies 5 Summary 6 About Oxford Nanopore Technologies 7 References OXFORD NANOPORE TECHNOLOGIES | THE ADVANTAGES OF LONG READS FOR GENOME ASSEMBLY Introduction Over the last decade, improvements in Whole genome assembly – next generation DNA sequencing solving the puzzle technology have transformed the field Traditional technologies have required of genomics, making it an essential tool users to sequence short lengths of DNA, in modern genetic and clinical research which must then be reassembled back laboratories. The facility to sequence into their original order as accurately as whole genomes or specific genomic possible. Such short-read sequencing regions of interest is delivering new insights technologies, however, present a number into a variety of applications such as of challenges, particularly the difficulty of human health and disease, metagenomics, accurately analysing repetitive regions and antimicrobial resistance, evolutionary large structural variations.1 biology and crop breeding. This means that many reference genomes that were created using short-read For applications such as the analysis of sequencing are highly fragmented, which larger structural variation, or de novo in turn introduces bias into any alignments assembly, whole genome sequencing made against that reference2. This review shows how these challenges are now (WGS) is typically the technique of choice.
    [Show full text]
  • Real-Time Nanopore-Based Recognition of Protein Translocation Success, Biophysical Journal (2018)
    Please cite this article in press as: Hoogerheide et al., Real-Time Nanopore-Based Recognition of Protein Translocation Success, Biophysical Journal (2018), https://doi.org/10.1016/j.bpj.2017.12.019 Biophysical Letter Real-Time Nanopore-Based Recognition of Protein Translocation Success David P. Hoogerheide,1,* Philip A. Gurnev,2 Tatiana K. Rostovtseva,2 and Sergey M. Bezrukov2,* 1Center for Neutron Research, National Institute of Standards and Technology, Gaithersburg, Maryland and 2Section on Molecular Transport, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland ABSTRACT A growing number of new technologies are supported by a single- or multi-nanopore architecture for capture, sensing, and delivery of polymeric biomolecules. Nanopore-based single-molecule DNA sequencing is the premier example. This method relies on the uniform linear charge density of DNA, so that each DNA strand is overwhelmingly likely to pass through the nanopore and across the separating membrane. For disordered peptides, folded proteins, or block copolymers with hetero- geneous charge densities, by contrast, translocation is not assured, and additional strategies to monitor the progress of the poly- mer molecule through a nanopore are required. Here, we demonstrate a single-molecule method for direct, model-free, real-time monitoring of the translocation of a disordered, heterogeneously charged polypeptide through a nanopore. The crucial elements are two ‘‘selectivity tags’’—regions of different but uniform charge density—at the ends of the polypeptide. These affect the selectivity of the nanopore differently and enable discrimination between polypeptide translocation and retraction. Our results demonstrate exquisite sensitivity of polypeptide translocation to applied transmembrane potential and prove the principle that nanopore selectivity reports on biopolymer substructure.
    [Show full text]